This message was posted by a user wishing to remain anonymous
I have an approved dossier and pdt is under commercialisation in EU. There is some deviation found from approved mfg process or parameters during commercial manufacturing and the QP reccomends to file a
batch specific variation to fullfill the deviation through EU post approval changes guidance.
My questions is:
What is this batch specific variation? is it a one time variation just to save the batch and avoid destruction?
Should I need to wait for approval of the variation till batch release or distribution in EU?
Should I conside its approval as life long approval on pdt? (Mean permanant change?)
Any EU guidance that help me to understand more about this?